Jamie I Fletcher

24PUBLICATIONS
165CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsGene and molecular therapyArts and cultural policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

|Nov 28, 2025
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma.

Jeremy Z R Han, Monica Phimmachanh, Jordan F Hastings

|Oct 01, 2025
High-throughput 3D engineered paediatric tumour models for precision medicine.

MoonSun Jung, Valentina Poltavets, Joanna N Skhinas

|Sep 16, 2025
NONO Maintains SREBP-Regulated Cholesterol Biosynthesis via RNA Binding in Neuroblastoma.

Song Zhang, Hayley Ingram, Jack Cooper

|Aug 06, 2025
The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity.

John Maris, Isabel Soria-Bretones, Matias Casás-Selves

|Jul 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy.

Nadine Azzam, Jamie I Fletcher, Nicole Melong

Pageof 4

Frequent Collaborators

13 joint publications

Michelle Haber

10 joint publications

Toby N Trahair

9 joint publications

Chelsea Mayoh

9 joint publications

Murray Norris